The Role of the Blood-Brain Barrier in the Pathogenesis of Senile Plaques in Alzheimer's Disease

International Journal of Alzheimer's Disease

Volumn 2014, Issue , 2014, Pages

  Provias, J ^a   Jeynes, B ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b BROCK UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; CARRIER PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MULTIDRUG RESISTANCE PROTEIN; VASCULOTROPIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN CAPILLARY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; NEUROPATHOLOGY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SENILE PLAQUE; TEMPORAL CORTEX;

EID: 84934986449     PISSN: 20908024     EISSN: 20900252     Source Type: Journal    
DOI: 10.1155/2014/191863     Document Type: Article

References (34)

1. H. M. Wisniewski, "Neuritic (senile) and amyloid plaques", in Alzheimer's Disease, B. Reisberg, Ed., pp. 57-61, Free Press, New York, NY, USA, 1983.
2. J. R. Steinerman, M. Irizarry, N. Scarmeas et al., "Distinct pools of β-amyloid in Alzheimer disease-affected brain: a clinicopathologic study", Archives of Neurology, vol. 65, no. 7, pp. 906-912, 2008.
3. J. A. Hardy and G. A. Higgins, "Alzheimer's disease: the amyloid cascade hypothesis", Science, vol. 256, no. 5054, pp. 184-185, 1992.
4. R. D. Bell and B. V. Zlokovic, "Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease", Acta Neuropathologica, vol. 118, no. 1, pp. 103-113, 2009.
5. B. Jeynes and J. Provias, "The case for blood-brain barrier dysfunction in the pathogenesis of Alzheimer's disease", Journal of Neuroscience Research, vol. 89, no. 1, pp. 22-28, 2011.
6. M. A. Erickson and W. A. Banks, "Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease", Journal of Cerebral Blood Flow and Metabolism, vol. 33, no. 10, pp. 1500-1513, 2013.
7. E. Farkas and P. G. M. Luiten, "Cerebral microvascular pathology in aging and Alzheimer's disease", Progress in Neurobiology, vol. 64, no. 6, pp. 575-611, 2001.
8. B. Jeynes and J. Provias, "The possible role of capillary cerebral amyloid angiopathy in Alzheimer lesion development: a regional comparison", Acta Neuropathologica, vol. 112, no. 4, pp. 417-427, 2006.
9. S. Burgmans, H. J. Van De Haar, F. R. J. Verhey, and W. H. Backes, "Amyloid-β interacts with blood-brain barrier function in dementia: a systematic review", Journal of Alzheimer's Disease, vol. 35, no. 4, pp. 859-873, 2013.
10. G. D. Silverberg, A. A. Messier, M. C. Miller et al., "Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging", Journal of Neuropathology and Experimental Neurology, vol. 69, no. 10, pp. 1034-1043, 2010.
11. B. Jeynes and J. Provias, "Evidence for altered LRP/RAGE expression in Alzheimer lesion pathogenesis", Current Alzheimer Research, vol. 5, no. 5, pp. 432-437, 2008.
12. E. Tarkowski, R. Issa, M. Sjögren et al., "Increased intrathecal levels of the angiogenic factors VEGF and TGF-β in Alzheimer's disease and vascular dementia", Neurobiology of Aging, vol. 23, no. 2, pp. 237-243, 2002.
13. L. Huang, J. Jia, and R. Liu, "Decreased serum levels of the angiogenic factors VEGF and TGF-β1 in Alzheimer's disease and amnesticmild cognitive impairment", Neuroscience Letters, vol. 550, no. 6, pp. 60-63, 2013.
14. A. Sanchez, D. Tripathy, J. Luo, X. Yin, J. Martinez, and P. Grammas, "Neurovascular unit and the effects of dosage in VEGF toxicity: role for oxidative stress and thrombin", Journal of Alzheimer's Disease, vol. 34, no. 1, pp. 281-291, 2013.
15. J. Zhao, T. O'Connor, and R. Vassar, "The contribution of activated astrocytes to Aβ production: implications for Alzheimer's disease pathogenesis", Journal of Neuroinflammation, vol. 8, article 150, 2011.
16. A.-C. Luissint, C. Artus, F. Glacial, K. Ganeshamoorthy, and P.-O. Couraud, "Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation", Fluids and Barriers of the CNS, vol. 9, no. 1, article 23, 2012.
17. H. Braak and E. Braak, "Neuropathological stageing of Alzheimerrelated changes", Acta Neuropathologica, vol. 82, no. 4, pp. 239-259, 1991.
18. S. S. Mirra, A. Heyman, D. McKeel et al., "The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease", Neurology, vol. 41, no. 4, pp. 479-486, 1991.
19. M. Ueno, T. Nakagawa, B. Wu et al., "Transporters in the brain endothelial barrier", Current Medicinal Chemistry, vol. 17, no. 12, pp. 1125-1138, 2010.
20. P. Religa, R. Cao, D. Religa et al., "VEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survival", Scientific Reports, vol. 3, no. 3, article 2053, 2013.
21. P. Grammas, "Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease", Journal of Neuroinflammation, vol. 8, article 26, 2011.
22. P. Grammas, A. Sanchez, D. Tripathy, E. Luo, and J. Martinez, "Vascular signaling abnormalities in Alzheimer disease", Cleveland Clinic Journal of Medicine, vol. 78, supplement 1, pp. S50-S53, 2011.
23. C. Spuch, S. Ortolano, and C. Navarro, "LRP-1 and LRP-2 receptors function in the membrane neuron. Trafficking mechanisms and proteolytic processing in alzheimer's disease", Frontiers in Physiology, vol. 3, article 269, 2012.
24. A. P. Sagare, R. Deane, and B. V. Zlokovic, "Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities", Pharmacology & Therapeutics, vol. 136, no. 1, pp. 94-105, 2012.
25. D. R. Dries, G. Yu, and J. Herz, "Extracting β-amyloid from Alzheimer's disease", Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 9, pp. 3199-3200, 2012.
26. T. Grimmer, O. Goldhardt, L.-H. Guo et al., "LRP-1 polymorphism is associated with global and regional amyloid load in Alzheimer's disease in humans in-vivo", Neuro Image: Clinical, vol. 4, pp. 411-416, 2014.
27. D. E. Kang, C. U. Pietrzik, L. Baum et al., "Modulation of amyloid β-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway", The Journal of Clinical Investigation, vol. 106, no. 9, pp. 1159-1166, 2000.
28. L. B. Jaeger, S. Dohgu, M. C. Hwang et al., "Testing the neurovascular hypothesis of alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-β protein, and impairs cognition", Journal of Alzheimer's Disease, vol. 17, no. 3, pp. 553-570, 2009.
29. H. C. Wijesuriya, J. Y. Bullock, R. L. M. Faull, S. B. Hladky, and M. A. Barrand, "ABC efflux transporters in brain vasculature of Alzheimer's subjects", Brain Research, vol. 1358, pp. 228-238, 2010.
30. B. Jeynes and J. Provias, "An investigation into the role of P-glycoprotein in Alzheimer's disease lesion pathogenesis", Neuroscience Letters, vol. 487, no. 3, pp. 389-393, 2011.
31. B. Jeynes and J. Provias, "P-glycoprotein altered expression in Alzheimer's disease: regional anatomic variability", Journal of Neurodegenerative Diseases, vol. 2013, Article ID 257953, 7 pages, 2013.
32. J. R. Cirrito, R. Deane, A. M. Fagan et al., "P-glycoprotein deficiency at the blood-brain barrier increases amyloid-β deposition in an Alzheimer disease mousemodel", Journal of Clinical Investigation, vol. 115, no. 11, pp. 3285-3290, 2005.
33. A. M. S. Hartz, D. S. Miller, and B. Bauer, "Restoring bloodbrain barrier P-glycoprotein reduces brain amyloid-β in a mouse model of Alzheimer's disease", Molecular Pharmacology, vol. 77, no. 5, pp. 715-723, 2010.
34. P. Candela, F. Gosselet, J. Saint-Pol et al., "Apical-to-basolateral transport through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein", Journal of Alzheimer's Disease, vol. 22, no. 3, pp. 849-859, 2010.